O

OMEICOS Therapeutics GmbH

9 employees

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Basic info

Industry

biotechnology research

Sectors

Health Care
Therapeutics
Drug development and Cardiovascular Research
Medical

Date founded

2013

Funding rounds raised

Total raised

$19M

from 16 investors over 16 rounds

O

OMEICOS Therapeutics GmbH raised $19M on November 2, 2018

Investors: Remiges Ventures, Inc., KG Investments, LLC, Vesalius Biocapital, KfW, Forbion and High-Tech Gründerfonds

O

OMEICOS Therapeutics GmbH raised undisclosed on October 4, 2017

Investors: Remiges Ventures, Inc.

O

OMEICOS Therapeutics GmbH raised $1.9M on June 7, 2017

Investors: Federal Ministry of Education and Research, Germany

O

OMEICOS Therapeutics GmbH raised $8.7M on March 1, 2017

Investors: Ascenion GmbH, Vesalius Biocapital and KfW

O

OMEICOS Therapeutics GmbH raised $6.6M on April 15, 2015

Investors: KfW, IBB Beteiligungsgesellschaft mbH, Vesalius Biocapital and High-Tech Gründerfonds

O

OMEICOS Therapeutics GmbH raised $675K on December 1, 2013

Investors: High-Tech Gründerfonds

FAQ